Oxcarbazepine treatment of bipolar disorder

Journal of Clinical Psychiatry

Volumn 64, Issue 8, 2003, Pages 943-945

  Ghaemi, S Nassir ^a,b   Berv, Douglas A ^c,d   Klugman, Jeffry ^c,d   Rosenquist, Klara J ^a   Hsu, Douglas J ^a  

^a CAMBRIDGE HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Atlantic Health Services   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXCARBAZEPINE;

ADOLESCENT; ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSIONS IMPROVEMENT SCALE SCORE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SEDATION; SEX DIFFERENCE; SIDE EFFECT; TREATMENT INDICATION;

EID: 0041510662     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v64n0813     Document Type: Article

References (13)

1. Ghaemi SN, Gaughan S. Novel anticonvulsants: a new generation of mood stabilizers? Harv Rev Psychiatry 2000;8:1-7
2. Post R, Denicoff K, Frye M, et al. Long-term outcome of anticonvulsants in affective disorders. In: Goldberg J, Harrow M, eds. Bipolar Disorders: Clinical Course and Outcome. Washington, DC: American Psychiatric Press; 1999:85-114
3. Ghaemi SN, Ko JY. Oxcarbazepine treatment of bipolar disorder: a review of the literature. Primary Psychiatry 2002;9:55-59
4. Muller AA, Stoll KD. Carbamazepine and oxcarbazepine in the treatment of manic syndromes: studies in Germany. In: Emrich HM, Okuma T, Muller AA, eds. Anticonvulsants in Affective Disorders. Amsterdam, the Netherlands: Excerpta Medica; 1984:139-147
5. Velinkoja M, Heinrich K. Effect of oxcarbazepine on affective and schizoaffective symptoms: a preliminary report. In: Emrich HM, Okuma T, Mueller AA, eds. Anticonvulsants in Affective Disorders. Amsterdam, the Netherlands: Excerpta Medica; 1984:208-210
6. Emrich H. Studies with oxcarbazepine (Trileptal) in acute mania. Int Clin Psychopharmacol 1990;5(suppl 1):83-88
7. Cabrera J, Muehlbauer H, Schley J, et al. Long-term randomized clinical trial on oxcarbazepine vs lithium in bipolar and schizoaffective disorders: preliminary results. Pharmacopsychiatry 1986;19:282-283
8. Greil W, Krueger R, Rossnagl G, et al. Prophylactic treatment of affective disorders with carbamazepine and oxcarbazepine: an open clinical trial. In: Pichot P, Berner P, Wolf R, et al, eds. Psychiatry: The State of the Art. New York, NY: Plenum Press; 1985:491-494
9. Tavormina G. Oxcarbazepine as a mood regulator: its efficacy, safety and tolerability vs carbamazepine [abstract]. Presented at the 22nd Collegium Internationale Neuro-Psychopharmacologicum; July 9-13, 2000; Brussels, Belgium
10. Hummel B, Stampfer R, Grunze H, et al. Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design [abstract]. Presented at the 4th International Conference on Bipolar Disorder; June 14-16, 2001; Pittsburgh, Pa
11. Reinstein M, Sonnenberg J, Chasanov M. Oxcarbazepine and divalproex sodium in mania [abstract]. Presented at the 154th annual meeting of the American Psychiatric Association; May 5-10, 2001; New Orleans, La
12. Ghaemi SN, Ko JY, Katzow JJ. Oxcarbazepine treatment of refractory bipolar disorder: a retrospective chart review. Bipolar Disord 2002;4: 70-74
13. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222